abstract |
Compounds, compositions and methods for treating diseases, syndromes, conditions and disorders affected by HBV CAM are disclosed. Such compounds are represented by formula (I) as follows: [Chemical 1] (wherein R 1 , R 2 , R 3 , X and R 4 are as defined herein). |